Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten F Gjerstorff

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Genes|March 6, 2021
HMGA2 as a Critical Regulator in Cancer DevelopmentBehzad Mansoori, Ali Mohammadi, Henrik J Ditzel, et al.
Cancers|December 23, 2022
PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast CancerMorten F Gjerstorff, Sofie Traynor, Odd L Gammelgaard, et al.
Human Reproduction (Oxford, England)|July 10, 2008
Distinct GAGE and MAGE-A expression during early human development indicate specific roles in lineage differentiationMorten F Gjerstorff, Linda Harkness, Moustapha Kassem, et al.
Photodiagnosis and Photodynamic Therapy|May 8, 2019
Photodynamic therapy for cancer: Role of natural productsBehzad Mansoori, Ali Mohammadi, Mohammad Amin Doustvandi, et al.
Frontiers in Immunology|May 11, 2026
Stable global repertoire architecture masks short-term clonal remodeling in intratumoral TCR repertoiresPernille G Pedersen, Odd L Gammelgaard, Sofie Traynor, et al.
Life Sciences|March 31, 2021
MiR-142-3p targets HMGA2 and suppresses breast cancer malignancyBehzad Mansoori, Pascal H G Duijf, Ali Mohammadi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 17, 2011
Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinumKatrine R Schoennemann, Jon K Bjerregaard, Tine P Hansen, et al.
Journal of Cellular Physiology|February 12, 2019
miR-142-3p is a tumor suppressor that inhibits estrogen receptor expression in ER-positive breast cancerBehzad Mansoori, Ali Mohammadi, Morten F Gjerstorff, et al.
Journal of Cellular Physiology|March 3, 2019
HMGA2 and Bach-1 cooperate to promote breast cancer cell malignancyBehzad Mansoori, Ali Mohammadi, Zahra Asadzadeh, et al.
Molecular Cancer|January 6, 2024
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasisOdd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Genes|March 6, 2021
HMGA2 as a Critical Regulator in Cancer DevelopmentBehzad Mansoori, Ali Mohammadi, Henrik J Ditzel, et al.
Cancers|December 23, 2022
PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast CancerMorten F Gjerstorff, Sofie Traynor, Odd L Gammelgaard, et al.
Human Reproduction (Oxford, England)|July 10, 2008
Distinct GAGE and MAGE-A expression during early human development indicate specific roles in lineage differentiationMorten F Gjerstorff, Linda Harkness, Moustapha Kassem, et al.
Photodiagnosis and Photodynamic Therapy|May 8, 2019
Photodynamic therapy for cancer: Role of natural productsBehzad Mansoori, Ali Mohammadi, Mohammad Amin Doustvandi, et al.
Frontiers in Immunology|May 11, 2026
Stable global repertoire architecture masks short-term clonal remodeling in intratumoral TCR repertoiresPernille G Pedersen, Odd L Gammelgaard, Sofie Traynor, et al.
Life Sciences|March 31, 2021
MiR-142-3p targets HMGA2 and suppresses breast cancer malignancyBehzad Mansoori, Pascal H G Duijf, Ali Mohammadi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 17, 2011
Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinumKatrine R Schoennemann, Jon K Bjerregaard, Tine P Hansen, et al.
Journal of Cellular Physiology|February 12, 2019
miR-142-3p is a tumor suppressor that inhibits estrogen receptor expression in ER-positive breast cancerBehzad Mansoori, Ali Mohammadi, Morten F Gjerstorff, et al.
Journal of Cellular Physiology|March 3, 2019
HMGA2 and Bach-1 cooperate to promote breast cancer cell malignancyBehzad Mansoori, Ali Mohammadi, Zahra Asadzadeh, et al.
Molecular Cancer|January 6, 2024
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasisOdd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin, et al.
Pageof 4